Medication Adherence studies

Poor medication adherence can lead to negative health outcomes including disability and premature death. Our researchers work with clinicians, pharmacists, and care teams at our Southern California medical centers to identify reasons patients do not take medications as prescribed and to test strategies to improve adherence.

Lipid-lowering therapy utilization among high-risk primary and secondary prevention populations

The overall goal of this study is to examine longitudinal LLT utilization patterns, including evaluating trajectories of LLT adherence, LLT switching, titration, and discontinuation in high risk patients who can benefit from primary or secondary prevention with LLT.

Principal Investigator:

Matthew T. Mefford, PhD, MS

Funding Source:

Merck & Co., Inc.

Funding Years:

2023 - 2024

Patterns and Predictors of Transitions in Adult Attention-Deficit Hyperactivity Disorder

This study will estimate the epidemiologic and economic outcomes associated with the adult attention deficit hyperactivity disorder (ADHD). We also assess characteristics, predictors, and time frame for patients who transition to more complex ADHD within the inception cohort and generate prediction models for transition. The study also examines treatment patterns, medication adherence and healthcare utilization patterns of the inception cohort.

Principal Investigator:

Aniket A. Kawatkar, PhD, MS

Funding Source:

Shire Pharmaceuticals

Funding Years:

2009 - 2012